Methylenedioxybutylamphetamine

MDBU
Clinical data
Other namesMDBU; 3,4-Methylenedioxy-N-butylamphetamine
Routes of
administration		Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • N-[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl]butan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H21NO2
Molar mass235.327 g·mol−1
3D model (JSmol)
  • C1=C2C(=CC=C1CC(C)NCCCC)OCO2
  • InChI=1S/C14H21NO2/c1-3-4-7-15-11(2)8-12-5-6-13-14(9-12)17-10-16-13/h5-6,9,11,15H,3-4,7-8,10H2,1-2H3
  • Key:RDXVRDCQDITVDV-UHFFFAOYSA-N

Methylenedioxybutylamphetamine (MDBU or 3,4-methylenedioxy-N-butylamphetamine) is a lesser-known drug.[1] It is also the N-butyl derivative of 3,4-methylenedioxyamphetamine (MDA).[1] MDBU was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, the minimum dose is listed as 40 mg, and the duration unknown.[1] MDBU produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MDBU.[1]

See also

References

  1. ^ a b c d e f g h Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. MDBU entry
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.